Home Biosimilar Antibodies Cytoskeletal Signaling Integrin antibody Bersanlimab (Anti-ICAM1 / CD54) For research use only.
Not for use in humans.

Bersanlimab (Anti-ICAM1 / CD54)

Synonyms: BI-505

Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.

Bersanlimab (Anti-ICAM1 / CD54)

Purity & Quality Control

Choose Selective Integrin Inhibitors

Name Citation Integrin
Cilengitide trifluoroacetate 66
A-205804 5
Cyclo(RGDyK) 13
SB273005 25
RGD (Arg-Gly-Asp) Peptides
ATN-161
Cyclo(-RGDfK) TFA
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Bersanlimab (Anti-ICAM1 / CD54) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects. MW: 145.5 KD.

Product Details

CAS No. 1987854-08-9
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Bersanlimab (Anti-ICAM1 / CD54) | Bersanlimab (Anti-ICAM1 / CD54) supplier | purchase Bersanlimab (Anti-ICAM1 / CD54) | Bersanlimab (Anti-ICAM1 / CD54) cost | Bersanlimab (Anti-ICAM1 / CD54) manufacturer | order Bersanlimab (Anti-ICAM1 / CD54) | Bersanlimab (Anti-ICAM1 / CD54) distributor